- +1 551 333 1547
- +44 2070 979277
- live:skype_chat
Veterinary Molecular Diagnostics Comprehensive Study by Type (Instruments, Consumables), Application (Livestock Animals, Companion Animals), Disease Type (Infectious Diseases, Oncology, Genetics, Microbiology), Technology (Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis), End-Use (Veterinary Reference Laboratories, Veterinary Hospitals and Clinics, Point-of-care/In-house Testing, Research Institutes and Universities) Players and Region - Global Market Outlook to 2027
Veterinary Molecular Diagnostics Market by XX Submarkets | Forecast Years 2022-2027
Market Overview:
A molecular diagnostic is a laboratory test that examines DNA, RNA, and other proteins in humans and animals to detect diseases or the predilection level. Veterinary molecular diagnostics have a range of advantages over other conventional diagnostic procedures, including a faster shift time of 2.5–3 hours, improved differentiation, and high test specificity and sensitivity among avirulant and birulent strains. The detection, recognition, and genotyping of pathogens are the primary goals of veterinary molecular diagnostics. These methods are used in veterinary diagnosis to diagnose diseases in individual animals and herds, as well as to determine the disease status of a herd. One of the major factors driving the growth and demand of the veterinary molecular diagnostics market is the rapid increase in the number of veterinary practitioners and the rise in income levels in developed economies. Furthermore, the demand for pet insurance and rising animal welfare spending are both leading to the global market's expansion. In addition, the demand for animal-derived food products and an increase in the incidence of animal zoonotic diseases are boosting the market's growth.| Attributes | Details |
|---|---|
| Study Period | 2017-2027 |
| Base Year | 2021 |
| Forecast Period | 2022-2027 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Million) |
| Key Companies Profiled | Trividia Health (United States), IDEXX Laboratories (United States), Abaxis, Zoetis (United States), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Neogen (United States), Virbac (France), Biomérieux SA (France) and Randox Laboratories (United Kingdom) |
| Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics by major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Key Players of Veterinary Molecular Diagnostics Market Study:
Trividia Health (United States), IDEXX Laboratories (United States), Abaxis, Zoetis (United States), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Neogen (United States), Virbac (France), Biomérieux SA (France) and Randox Laboratories (United Kingdom)In the last few years, Global market of Veterinary Molecular Diagnostics developed rapidly. Major factors driving the market are Rise in Prevalence of Animal Diseases .
On the basis of product type, the Veterinary Molecular Diagnostics market is segmented by Instruments and Consumables.
On the basis of applications, the Veterinary Molecular Diagnostics market is segmented by Livestock Animals and Companion Animals.
Latest Industry Highlights:
October 2020 – Trividia Health has released a pet-monitoring blood glucose system, Test Buddy, which is meant to help dogs and cats with diabetes. and August 2020 – IDEXX Laboratoriesa global leader in veterinary diagnostics and software, announced the launch of the ProCyte OneHematology Analyzer. The new analyzer's advanced technology delivers breakthrough workflow simplicity and consistent, accurate results at the point of care.. Some of the other players that are also part of study are IDvet (France) and BioChek B.V. (Netherlands). The Global Veterinary Molecular Diagnostics market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Veterinary Molecular Diagnostics market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Veterinary Molecular Diagnostics market.
Identification of total players or companies operating in the global market which is further concentrated to a fewer or most impacting players which is considered under the report’s scope. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Veterinary Molecular Diagnostics Devices, Suppliers of Veterinary Molecular Diagnostics Devices, Research Institutes and Universities, Medical Device Manufacturers and Governmental Bodies.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
- Instruments
- Consumables
By Application
- Livestock Animals
- Companion Animals
By Disease Type
- Infectious Diseases
- Oncology
- Genetics
- Microbiology
By Technology
- Clinical Biochemistry
- Molecular Diagnostics
- Hematology
- Urinalysis
By End-Use
- Veterinary Reference Laboratories
- Veterinary Hospitals and Clinics
- Point-of-care/In-house Testing
- Research Institutes and Universities
By Regions
- South America
- Brazil
- Argentina
- Rest of South America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Taiwan
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- Italy
- United Kingdom
- Netherlands
- Rest of Europe
- MEA
- Middle East
- Africa
- North America
- United States
- Canada
- Mexico
- 1. Market Overview
- 1.1. Introduction
- 1.2. Scope/Objective of the Study
- 1.2.1. Research Objective
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rise in Prevalence of Animal Diseases
- 3.2.2. Increase in Demand for Animal-derived Proteins
- 3.2.3. Growth in Animal Health Expenditure
- 3.3. Market Challenges
- 3.3.1. Lack of Animal Healthcare Awareness in Emerging Markets
- 3.3.2. Shortage of Veterinarians in Emerging Markets
- 3.4. Market Trends
- 3.4.1. Advanced Monitoring Blood Glucose Systems
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 5. Global Veterinary Molecular Diagnostics, by Type, Application, Disease Type, Technology, End-Use and Region (value) (2016-2021)
- 5.1. Introduction
- 6. Veterinary Molecular Diagnostics: Manufacturers/Players Analysis
- 6.1. Company Profile
- 6.1.1. Trividia Health (United States)
- 6.1.1.1. Business Overview
- 6.1.1.2. Products/Services Offerings
- 6.1.1.3. Financial Analysis
- 6.1.1.4. SWOT Analysis
- 6.1.2. IDEXX Laboratories (United States)
- 6.1.2.1. Business Overview
- 6.1.2.2. Products/Services Offerings
- 6.1.2.3. Financial Analysis
- 6.1.2.4. SWOT Analysis
- 6.1.3. Abaxis
- 6.1.3.1. Business Overview
- 6.1.3.2. Products/Services Offerings
- 6.1.3.3. Financial Analysis
- 6.1.3.4. SWOT Analysis
- 6.1.4. Zoetis (United States)
- 6.1.4.1. Business Overview
- 6.1.4.2. Products/Services Offerings
- 6.1.4.3. Financial Analysis
- 6.1.4.4. SWOT Analysis
- 6.1.5. QIAGEN N.V. (Netherlands)
- 6.1.5.1. Business Overview
- 6.1.5.2. Products/Services Offerings
- 6.1.5.3. Financial Analysis
- 6.1.5.4. SWOT Analysis
- 6.1.6. Thermo Fisher Scientific
- 6.1.6.1. Business Overview
- 6.1.6.2. Products/Services Offerings
- 6.1.6.3. Financial Analysis
- 6.1.6.4. SWOT Analysis
- 6.1.7. Neogen (United States)
- 6.1.7.1. Business Overview
- 6.1.7.2. Products/Services Offerings
- 6.1.7.3. Financial Analysis
- 6.1.7.4. SWOT Analysis
- 6.1.8. Virbac (France)
- 6.1.8.1. Business Overview
- 6.1.8.2. Products/Services Offerings
- 6.1.8.3. Financial Analysis
- 6.1.8.4. SWOT Analysis
- 6.1.9. Biomérieux SA (France)
- 6.1.9.1. Business Overview
- 6.1.9.2. Products/Services Offerings
- 6.1.9.3. Financial Analysis
- 6.1.9.4. SWOT Analysis
- 6.1.10. Randox Laboratories (United Kingdom)
- 6.1.10.1. Business Overview
- 6.1.10.2. Products/Services Offerings
- 6.1.10.3. Financial Analysis
- 6.1.10.4. SWOT Analysis
- 6.1.1. Trividia Health (United States)
- 6.1. Company Profile
- 7. Global Veterinary Molecular Diagnostics Sale, by Type, Application, Disease Type, Technology, End-Use and Region (value) (2022-2027)
- 7.1. Introduction
- 8. Appendix
- 8.1. Acronyms
- 9. Methodology and Data Source
- 9.1. Methodology/Research Approach
- 9.1.1. Research Programs/Design
- 9.1.2. Market Size Estimation
- 9.1.3. Market Breakdown and Data Triangulation
- 9.2. Data Source
- 9.2.1. Secondary Sources
- 9.2.2. Primary Sources
- 9.3. Disclaimer
- 9.1. Methodology/Research Approach
List of Tables
- Table 1. Company Basic Information, Sales Area and Its Competitors
- Table 2. Company Basic Information, Sales Area and Its Competitors
- Table 3. Company Basic Information, Sales Area and Its Competitors
- Table 4. Company Basic Information, Sales Area and Its Competitors
- Table 5. Company Basic Information, Sales Area and Its Competitors
- Table 6. Company Basic Information, Sales Area and Its Competitors
- Table 7. Company Basic Information, Sales Area and Its Competitors
- Table 8. Company Basic Information, Sales Area and Its Competitors
- Table 9. Company Basic Information, Sales Area and Its Competitors
- Table 10. Company Basic Information, Sales Area and Its Competitors
- Table 11. Research Programs/Design for This Report
- Table 12. Key Data Information from Secondary Sources
- Table 13. Key Data Information from Primary Sources
List of Figures
- Figure 1. Porters Five Forces
- Figure 2. Supply/Value Chain
- Figure 3. PESTEL analysis
- Figure 4. Trividia Health (United States) Revenue, Net Income and Gross profit
- Figure 5. Trividia Health (United States) Revenue: by Geography 2021
- Figure 6. IDEXX Laboratories (United States) Revenue, Net Income and Gross profit
- Figure 7. IDEXX Laboratories (United States) Revenue: by Geography 2021
- Figure 8. Abaxis Revenue, Net Income and Gross profit
- Figure 9. Abaxis Revenue: by Geography 2021
- Figure 10. Zoetis (United States) Revenue, Net Income and Gross profit
- Figure 11. Zoetis (United States) Revenue: by Geography 2021
- Figure 12. QIAGEN N.V. (Netherlands) Revenue, Net Income and Gross profit
- Figure 13. QIAGEN N.V. (Netherlands) Revenue: by Geography 2021
- Figure 14. Thermo Fisher Scientific Revenue, Net Income and Gross profit
- Figure 15. Thermo Fisher Scientific Revenue: by Geography 2021
- Figure 16. Neogen (United States) Revenue, Net Income and Gross profit
- Figure 17. Neogen (United States) Revenue: by Geography 2021
- Figure 18. Virbac (France) Revenue, Net Income and Gross profit
- Figure 19. Virbac (France) Revenue: by Geography 2021
- Figure 20. Biomérieux SA (France) Revenue, Net Income and Gross profit
- Figure 21. Biomérieux SA (France) Revenue: by Geography 2021
- Figure 22. Randox Laboratories (United Kingdom) Revenue, Net Income and Gross profit
- Figure 23. Randox Laboratories (United Kingdom) Revenue: by Geography 2021
List of companies from research coverage that are profiled in the study
- Trividia Health (United States)
- IDEXX Laboratories (United States)
- Abaxis
- Zoetis (United States)
- QIAGEN N.V. (Netherlands)
- Thermo Fisher Scientific
- Neogen (United States)
- Virbac (France)
- Biomérieux SA (France)
- Randox Laboratories (United Kingdom)
Additional players considered in the study are as follows:
IDvet (France)
,
BioChek B.V. (Netherlands)
Select User Access Type
Key Highlights of Report
Jun 2022
156 Pages
77 Tables
Base Year: 2021
Coverage: 15+ Companies; 18 Countries
Request Sample Pages
Budget constraints? Get in touch with us for special pricing
Check Discount Now
Talk to Our Experts
Want to Customize Study?
"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."
Frequently Asked Questions (FAQ):
"Advanced Monitoring Blood Glucose Systems" is seen as one of major influencing trends for Veterinary Molecular Diagnostics Market during projected period 2021-2027.
The Concentration Rate of Global Veterinary Molecular Diagnostics market is highlighted using HHI Index.
United States Players will contribute the maximum growth of Global Veterinary Molecular Diagnostics market throughout the predicted period.